Prof William Gallagher

Full Professor of Cancer Biology, University College Dublin
Co-Lead, All-Island Cancer Research Institute (AICRI)
Scientific Director, St. Vincent’s-UCD Cancer Centre

Professor William Gallagher is Full Professor of Cancer Biology at University College Dublin (UCD) and Deputy Academic Director of the Research Ireland ARC Hub for Therapeutics, a newly established life sciences accelerator in Ireland. Currently, Prof. Gallagher is a primary driving force behind the All-Island Cancer Research Institute (AICRI), which is creating an overarching framework for cancer research across the entire island of Ireland (www.aicri.org). AICRI-linked programmes were awarded over 12 million euro under the HEA North-South Research Programme, including an all-island Doctoral and Post-Doctoral Training Programme in Precision Cancer Medicine (AICRIstart) which Prof. Gallagher co-leads, together with Prof. Mark Lawler (Queen’s University Belfast). Prof. Gallagher has received a number of awards for his research and innovation achievements in the oncology arena, including the inaugural Irish Association for Cancer Research Medal in 2017, the SFI Entrepreneurship Award in 2019 and the SFI Researcher of the Year Award in 2021. Prof. Gallagher has co-founded two molecular diagnostics companies, OncoMark Ltd. and OncoAssure Ltd., the former being acquired in March 2021 by the US company Danaher (Cepheid division).

Updated: April 2026